Prednisone-free maintenance immunosuppression-a 5-year experience.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 16162197)

Published in Am J Transplant on October 01, 2005

Authors

Arthur J Matas1, Raja Kandaswamy, Kristen J Gillingham, Lois McHugh, Hassan Ibrahim, Bertram Kasiske, Abhinav Humar

Author Affiliations

1: Department of Surgery, University of Minnesota, Minneapolis, USA. matas001@umn.edu

Articles citing this

Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant (2008) 1.75

Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03

Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy (2011) 1.02

2202 kidney transplant recipients with 10 years of graft function: what happens next? Am J Transplant (2008) 1.02

Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant (2009) 0.96

Renal transplantation with early steroid withdrawal. Pediatr Nephrol (2008) 0.88

Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy. Transplantation (2009) 0.88

Cardiovascular disease in transplant recipients: current and future treatment strategies. Clin J Am Soc Nephrol (2008) 0.86

Thymoglobulin--new approaches to optimal outcomes. J Med Life (2010) 0.85

New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity. Drugs (2014) 0.84

Recurrent glomerulonephritis under rapid discontinuation of steroids. Transplantation (2011) 0.82

Early steroid withdrawal in pediatric renal transplant: five years of follow-up. Pediatr Nephrol (2011) 0.82

Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. Am J Transplant (2013) 0.80

Early steroid withdrawal in repeat kidney transplantation. Clin J Am Soc Nephrol (2010) 0.78

Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal. J Transplant (2011) 0.76

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation. Transplant Res (2014) 0.75

Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med (2017) 0.75

Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type. World J Transplant (2014) 0.75

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies? Am J Transplant (2016) 0.75

Role of steroid maintenance in sensitized kidney transplant recipients. World J Transplant (2015) 0.75

Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers. Int J Clin Med (2016) 0.75

Articles by these authors

International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis (2012) 5.70

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA (2005) 4.48

Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol (2003) 3.48

US Renal Data System 2010 Annual Data Report. Am J Kidney Dis (2011) 2.90

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2005) 2.81

Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant (2004) 2.55

US Renal Data System 2012 Annual Data Report. Am J Kidney Dis (2013) 2.54

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis (2009) 2.43

Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2011) 2.28

Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth (2010) 2.26

Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16

United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14

Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis (2008) 2.01

Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol (2007) 1.94

Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol (2013) 1.77

Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis (2003) 1.70

Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation. Clin J Am Soc Nephrol (2012) 1.69

Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl (2011) 1.63

Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type. Transplantation (2008) 1.58

Five preventable causes of kidney graft loss in the 1990s: a single-center analysis. Kidney Int (2002) 1.53

Blunt traumatic injuries of the lung parenchyma, pleura, thoracic wall, and intrathoracic airways: multidetector computer tomography imaging findings. Emerg Radiol (2007) 1.52

Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51

Kidney and pancreas transplantation. Am J Transplant (2003) 1.45

Graft loss due to recurrent disease in pediatric kidney transplant recipients on a rapid prednisone discontinuation protocol. Pediatr Transplant (2012) 1.42

Biliary stricture in living-related donor liver transplantation: management with balloon dilation. Pediatr Transplant (2002) 1.39

Risk factors and treatment success for ureteral obstruction after pediatric renal transplantation. J Urol (2010) 1.39

Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol (2009) 1.34

Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant (2009) 1.31

Serum uric acid and risk of ischemic stroke: the ARIC Study. Atherosclerosis (2005) 1.25

Outcomes of pancreas transplants for patients with type 2 diabetes mellitus. Clin Transplant (2005) 1.23

Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg (2009) 1.21

Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology (2012) 1.21

Improvement in islet yield from obese donors for human islet transplants. Transplantation (2004) 1.19

Technical failures after pancreas transplants: why grafts fail and the risk factors--a multivariate analysis. Transplantation (2004) 1.12

Laparoscopic stapled left lateral segment liver resection--technique and results. J Gastrointest Surg (2003) 1.10

A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients--an interim analysis. Am J Transplant (2005) 1.09

Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol (2002) 1.09

Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation (2008) 1.08

Radiofrequency ablation causes 'thermal fixation' of hepatocellular carcinoma: a post-liver transplant histopathologic study. Clin Transplant (2003) 1.07

Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation (2003) 1.05

Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg (2004) 1.04

GFR-estimating models in kidney transplant recipients on a steroid-free regimen. Nephrol Dial Transplant (2010) 1.04

Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth (2011) 1.03

Risk factors for frequent readmissions and barriers to transplantation in patients with cirrhosis. PLoS One (2013) 0.98

Outcome at 3 years with a prednisone-free maintenance regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant (2004) 0.97

A report of the Lisbon Conference on the care of the kidney transplant recipient. Transplantation (2007) 0.97

Prevention of poor psychosocial outcomes in living organ donors: from description to theory-driven intervention development and initial feasibility testing. Prog Transplant (2012) 0.96

Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol. Transplantation (2006) 0.95

Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report. Transplantation (2005) 0.93

Diabetic gastroparesis-associated bezoar resolution via "cola-lysis". Clin Transplant (2008) 0.92

Segmental absence of intestinal musculature (SAIM): a case report in an adult. BMJ Case Rep (2009) 0.91

Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. Transplantation (2011) 0.91

Effects of sex on renal structure. Nephron (2002) 0.91

Calcineurin inhibitor- and steroid-free immunosuppression in pancreas-kidney and solitary pancreas transplantation. Transplantation (2005) 0.91

Pediatric kidney transplantation using a novel protocol of rapid (6-day) discontinuation of prednisone: 2-year results. Transplantation (2009) 0.91

Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection. Transplantation (2008) 0.91

Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol (2008) 0.90

Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation (2002) 0.90

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation (2004) 0.90

Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation (2003) 0.89

Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg (2009) 0.88

Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy. Clin Transplant (2006) 0.88

Laparoscopic donor distal pancreatectomy for living donor pancreas and pancreas-kidney transplantation. Am J Transplant (2005) 0.88

Presentation and outcomes of hepatocellular carcinoma patients at a western centre. HPB (Oxford) (2011) 0.86

Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities. Surgery (2013) 0.86

Increased expression of peripheral blood leukocyte genes implicate CD14+ tissue macrophages in cellular intestine allograft rejection. Am J Pathol (2011) 0.86

Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome. Transplantation (2008) 0.86

Surrogate markers for long-term renal allograft survival. Am J Transplant (2004) 0.85

Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. J Vasc Interv Radiol (2013) 0.85

Risk factors and impact of delayed graft function after pancreas transplants. Am J Transplant (2004) 0.85

Comparison of a silicon carbide coated stent versus a noncoated stent in humans: the Tenax- versus Nir-Stent Study (TENISS). J Interv Cardiol (2003) 0.85

A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors. Am J Transplant (2005) 0.85

A validated model for predicting outcome after liver transplantation: implications on transplanting the extremely sick. Transpl Int (2013) 0.85

Graft weight/recipient weight ratio: how well does it predict outcome after partial liver transplants? Liver Transpl (2009) 0.85

Kidney transplant patients' perceptions, beliefs, and barriers related to regular nephrology outpatient visits. Am J Kidney Dis (2010) 0.84

Pushing the envelope: living donor pancreas transplantation. Curr Opin Organ Transplant (2012) 0.84

Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop. Pancreas (2014) 0.84

What happens to the kidney in an SPK transplant when the pancreas fails due to a technical complication? Clin Transplant (2008) 0.84

Risk factors for rising creatinine in renal allografts with 1 and 3 yr survival. Clin Transplant (2006) 0.84